| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A review of the safety of favipiravir – a potential treatment in the COVID-19 pandemic?
|
Pilkington, Victoria
|
|
|
6 |
2 |
p. 45-51
|
artikel
|
| 2 |
Editorial
|
|
|
|
6 |
2 |
p. i
|
artikel
|
| 3 |
Highlights of the 9th edition of the Conference on HIV Persistence During Therapy, 10–13 December 2019, Miami, USA
|
Psomas, ChristinaK
|
|
|
6 |
2 |
p. 85-95
|
artikel
|
| 4 |
‘Informed and empowered’: a mixed-methods study of crowdsourcing contests to promote uptake of HIV self-testing kits among African Americans
|
Mathews, Allison
|
|
|
6 |
2 |
p. 74-80
|
artikel
|
| 5 |
Minimum costs to manufacture new treatments for COVID-19
|
Hill, Andrew
|
|
|
6 |
2 |
p. 61-69
|
artikel
|
| 6 |
Phase 3 trials of new antiretrovirals are not representative of the global HIV epidemic
|
Pepperrell, Toby
|
|
|
6 |
2 |
p. 70-73
|
artikel
|
| 7 |
Review of safety and minimum pricing of nitazoxanide for potential treatment of COVID-19
|
Pepperrell, Toby
|
|
|
6 |
2 |
p. 52-60
|
artikel
|
| 8 |
Summary of the coronavirus disease 2019 (COVID-19) update from the 2020 Conference on Retroviruses and Opportunistic Infections, 8–11 March 2020, Boston, USA
|
Psomas, Christina K.
|
|
|
6 |
2 |
p. 96-99
|
artikel
|
| 9 |
Willingness to risk death endpoint in HIV cure-related research with otherwise healthy volunteers is misleading
|
Dubé, Karine
|
|
|
6 |
2 |
p. 81-84
|
artikel
|
Tijdschrift beschrijving